News-Chart Neumora Therapeutics, Inc.

Aktien

A3EVX4

US6409791000

NMRA

Realtime-Estimate Cboe BZX Andere Börsenplätze 20:51:41 05.06.2024			% 5 Tage	% 1. Jan.
9.92 ^USD	-0.80%		+4.42%	-41.76%

14.05.	Transcript : Neumora Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:00 AM
14.05.	Neumora Therapeutics, Inc. kündigt Beginn einer Phase-2-Studie mit Navacaprant bei bipolarer Depression an	CI

5a497384c2bef93723bb7538ff10.GxxR2jC7P6hTAbhHh2aTlJIhTuPVML318Q2enqaeNc8.UFAQvWHhfMIGMP0w_1CjxeVIB42PRvzEx0mt0civBqx5VgO1aP9M2CtH8Q~c30310e53ab00b88a37b41dc1498b254